DOI 10.1007/s11010-026-05735-3
Mitochondria-mediated anticancer effects of two previously characterized COX-2 inhibitors in hepatocellular carcinoma.
Аннотация
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality and often shows limited response to current therapies like sorafenib. This study investigates the selective anticancer activity and mitochondria-mediated apoptotic effects of two previously characterized COX-2 inhibitors, ZMA-M3 (imidazo[1,2-a]pyrazine) and ZMA-M4 (imidazo[1,2-a]pyridine), in isolated HCC and normal rat hepatocytes. Isolated HCC and normal rat hepatocytes were treated with various concentrations of ZMA-M3 and ZMA-M4 to determine their half-maximal inhibitory concentrations (IC50). Apoptosis was evaluated using Annexin V-FITC/PI staining and caspase-3 activity assays. Mitochondrial dysfunction was assessed by measuring reactive oxygen species (ROS) generation, mitochondrial membrane potential (MMP) collapse, mitochondrial swelling, and cytochrome c release. Isolated HCC and normal rat hepatocytes were treated with various concentrations of ZMA-M3 and ZMA-M4 to determine their half-maximal inhibitory concentrations (IC50). Apoptosis was evaluated using Annexin V-FITC/PI staining and caspase-3 activity assays. Mitochondrial dysfunction was assessed by measuring reactive oxygen species (ROS) generation, mitochondrial membrane potential (MMP) collapse, mitochondrial swelling, and cytochrome c release.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.